Melinta Therapeutics
Founded in 2000, Melinta Therapeutics biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings. The company is headquartered in New Haven Connecticut.
Last updated on
About Melinta Therapeutics
Founded
2000Estimated Revenue
$50M-$100MEmployees
251-1KFunding / Mkt. Cap
$30MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
55Location
City
MorristownState
New JerseyCountry
United StatesTech Stack (71)
